-
公开(公告)号:US08362035B2
公开(公告)日:2013-01-29
申请号:US13541158
申请日:2012-07-03
IPC分类号: A61K31/4709 , A61K31/427 , A61K31/4025 , C07D215/233 , C07D417/14 , C07D207/12
CPC分类号: C07D417/14
摘要: This invention relates to novel crystalline forms of the following Compound (1), and the sodium salt thereof, and methods for the preparation thereof, pharmaceutical compositions thereof, and their use in the treatment of Hepatitis C Viral (HCV) infection:
摘要翻译: 本发明涉及以下化合物(1)的新型结晶形式及其钠盐及其制备方法,其药物组合物及其在治疗丙型肝炎病毒(HCV)感染中的用途:
-
公开(公告)号:US08232293B2
公开(公告)日:2012-07-31
申请号:US12559927
申请日:2009-09-15
IPC分类号: A61K31/4709 , A61K31/427 , A61K31/4025 , C07D215/233 , C07D417/14 , C07D207/12
CPC分类号: C07D417/14
摘要: This invention relates to novel crystalline forms of the following Compound (1), and the sodium salt thereof, and methods for the preparation thereof, pharmaceutical compositions thereof, and their use in the treatment of Hepatitis C Viral (HCV) infection:
摘要翻译: 本发明涉及以下化合物(1)的新型结晶形式及其钠盐及其制备方法,其药物组合物及其在治疗丙型肝炎病毒(HCV)感染中的用途:
-